Highlights from the American Thoracic Society (ATS) Guidelines 2020
Industry Webcast Sponsored by Boehringer Ingelheim Pharmaceuticals, Inc.; Not for CME/CE Credit
Understanding the six ATS recommendations on the pharmacologic treatment of stable COPD.
This content is developed exclusively by or on behalf of the industry sponsor through a third party and is not reviewed by Pri-Med. The content and opinions expressed are those of the sponsor or presenters and may not reflect the views of Pri-Med.